Personal Finance from Forbes.com:
 
3 Growth Stocks Seen As Attractive Timely Plays On Economic Recovery
2/8/2012 5:50 AM
Even as the cyclicals are getting fresh attention on Wall Street because of the rejuvenated economic recovery, some market watchers expect growth stocks to also resurge and regain momentum soon. ...Read More
 
New Zealand: Economic Paradise
2/7/2012 11:03 PM
In Freedom Investing 2012 I analyzed the latest Index of Economic Freedom from The Heritage Foundation. Here I present some of the analysis for New Zealand, the fourth highest country in economic freedom...Read More
 
Valentine's Day.....What If ????
2/7/2012 4:45 PM
Valentine’s Day. Here it comes, filled with high expectations and commercial pressure. Almost makes you want to protest even the need for the day. ...Read More
 
The Safest Small Cars
2/7/2012 3:35 PM
The good news is that traffic fatalities are at historic lows, thanks in large part to increasingly sophisticated auto designs, advanced safety features and stricter seatbelt and DUI laws. The bad news is auto crashes still accounted for 32,788 deaths in 2010, according to the National Highway Traffic Safety Administration, which means a vehicle-re...Read More
 
The Safest Small Cars
2/7/2012 3:35 PM
The laws of physics always favor a larger car in a collision. That’s why it’s critical to choose a small car that gets top crash-test ratings and offers an extensive assortment of safety features...Read More
 
Same Sex Marriage
2/7/2012 3:34 PM
...Read More
 
Federal Court Strikes California Ban On Same-Sex Marriage
2/7/2012 3:34 PM
A federal appeals court ruled today that California's ban on same-sex marriage violates the U.S. Constitution...Read More
 
Daily Dividend Report: MA, EMR, TSN, CCE, AGNC
2/7/2012 3:03 PM
Mastercard Incorporated (MA) announced its quarterly dividend of 30 cents per share, an increase of about 100% over its prior dividend in January of 15 cents. The dividend will be paid on May 9 to shareholders on record as of April 9...Read More
 
Analyst Moves: AMLN, HCA
2/7/2012 3:01 PM
Amylin Pharmaceuticals (AMLN) today had its price target raised to $30 with a buy rating by Jefferies (JEF). Guidance issued by the company seems to suggest increased sales of the Exenatide product...Read More
 
How The IRS Is Catching Taxpayers Who Underreport Retirement Income
2/7/2012 2:33 PM
...Read More



These articles are property of Forbes.com and protected by copyright.